Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 17.6%

VanEck Biotech ETF (NASDAQ:BBH) was the target of a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 1,400 shares, a decline of 17.6% from the December 31st total of 1,700 shares. Based on an average trading volume of 10,800 shares, the days-to-cover ratio is presently 0.1 days.

VanEck Biotech ETF Stock Up 0.3 %

Shares of BBH stock traded up $0.54 on Monday, reaching $165.79. The company had a trading volume of 3,517 shares, compared to its average volume of 11,331. The business’s 50-day moving average is $161.97 and its 200 day moving average is $170.83. VanEck Biotech ETF has a one year low of $151.35 and a one year high of $183.64.

VanEck Biotech ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Tuesday, December 24th. Shareholders of record on Monday, December 23rd were issued a $1.2517 dividend. The ex-dividend date was Monday, December 23rd.

Institutional Investors Weigh In On VanEck Biotech ETF

A number of large investors have recently bought and sold shares of BBH. International Assets Investment Management LLC raised its stake in shares of VanEck Biotech ETF by 10,376,390.9% in the third quarter. International Assets Investment Management LLC now owns 1,141,414 shares of the company’s stock worth $202,475,000 after purchasing an additional 1,141,403 shares during the last quarter. Strategic Financial Concepts LLC purchased a new stake in VanEck Biotech ETF in the 4th quarter valued at $3,828,000. Northwestern Mutual Wealth Management Co. boosted its holdings in VanEck Biotech ETF by 5.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 24,324 shares of the company’s stock worth $4,096,000 after acquiring an additional 1,334 shares during the last quarter. Jane Street Group LLC lifted its position in shares of VanEck Biotech ETF by 401.7% during the third quarter. Jane Street Group LLC now owns 8,348 shares of the company’s stock valued at $1,481,000 after purchasing an additional 6,684 shares in the last quarter. Finally, Kovitz Investment Group Partners LLC boosted its holdings in VanEck Biotech ETF by 4.6% during the third quarter. Kovitz Investment Group Partners LLC now owns 3,186 shares of the company’s stock worth $565,000 after purchasing an additional 141 shares during the last quarter. 32.05% of the stock is currently owned by institutional investors and hedge funds.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.